Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of a Hybrid Closed-Loop Artificial Pancreas System in Patients With Latent Autoimmune Diabetes in Adults (LADA): An Open-Label, Randomized Controlled Trial

NCT06941675 is registered in ClinicalTrials.gov with Shanxi Bethune Hospital as lead sponsor.

NCT NCT06941675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06941675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of a Hybrid Closed-Loop Artificial Pancreas System in Patients With Latent Autoimmune Diabetes in Adults (LADA): An Open-Label, Randomized Controlled Trial
Lead sponsor
Shanxi Bethune Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2025
Completion date
August 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

latent autoimmune diabetes in adults (lada)